Post-Chemotherapy Antibody-Based Continuation and Maintenance Strategies in HER2-Positive Metastatic Breast Cancer: A Translational Narrative Review.

Pogoda K, Lewińska K, Kalman P, Bałata A, Wysocki PJ

Open source

DOI
10.3390/antib15020036
Published
2026 Apr 16
Container
Antibodies (Basel, Switzerland)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/antib15020036,
  title = {Post-Chemotherapy Antibody-Based Continuation and Maintenance Strategies in HER2-Positive Metastatic Breast Cancer: A Translational Narrative Review.},
  author = {Pogoda K and Lewińska K and Kalman P and Bałata A and Wysocki PJ},
  year = {2026},
  journal = {Antibodies (Basel, Switzerland)},
  doi = {10.3390/antib15020036},
  url = {https://doi.org/10.3390/antib15020036}
}

RIS

TY  - JOUR
TI  - Post-Chemotherapy Antibody-Based Continuation and Maintenance Strategies in HER2-Positive Metastatic Breast Cancer: A Translational Narrative Review.
AU  - Pogoda K
AU  - Lewińska K
AU  - Kalman P
AU  - Bałata A
AU  - Wysocki PJ
PY  - 2026
JO  - Antibodies (Basel, Switzerland)
DO  - 10.3390/antib15020036
UR  - https://doi.org/10.3390/antib15020036
ER  - 

APA

K, P., K, L., P, K., A, B., & PJ, W. (2026). Post-Chemotherapy Antibody-Based Continuation and Maintenance Strategies in HER2-Positive Metastatic Breast Cancer: A Translational Narrative Review.. Antibodies (Basel, Switzerland). https://doi.org/10.3390/antib15020036

Source records